The Treatment of Onychauxis in the Foot

Onychauxis is a common nail pathology characterised by a uniform thickening and hypertrophy of the nail plate, typically without significant structural deformity or lateral deviation. Often confused with onychogryphosis — a more severe condition involving pronounced curvature and distortion — onychauxis presents as a straightforward, though clinically significant, overgrowth of the nail. It most frequently affects the toenails, particularly the hallux (great toe), and is encountered regularly in podiatric practice. While the condition is not inherently dangerous, untreated onychauxis can lead to pain, subungual pressure, secondary infection, and considerable reduction in quality of life, particularly in elderly or immunocompromised populations. Understanding the aetiology, clinical presentation, and range of treatment options is essential for effective podiatric management.

Aetiology and Predisposing Factors

Onychauxis arises from a disruption in the normal mitotic activity of the nail matrix, which results in accelerated or abnormal nail cell production. This can be triggered by a variety of intrinsic and extrinsic factors. Repeated microtrauma — commonly caused by poorly fitting footwear, athletic activity, or prolonged pressure on the nail — is among the most frequent causes. The nail matrix, responding to chronic insult, overproduces keratinocytes, leading to progressive thickening of the nail plate over time.

Systemic conditions also play a significant aetiological role. Peripheral vascular disease, diabetes mellitus, and other conditions associated with poor circulation impair normal nail growth and repair mechanisms. Psoriasis is a notable dermatological cause, as it can affect the matrix and nail bed, producing thickened, dystrophic nails. Fungal infections, particularly onychomycosis caused by dermatophytes, are a major contributor to nail hypertrophy and must be differentiated from — or identified as co-existing with — onychauxis prior to formulating a treatment plan. Age-related changes in nail growth, circulation, and tissue elasticity mean that onychauxis is particularly prevalent in older adults.

Clinical Presentation and Assessment

Clinically, onychauxis presents as a uniformly thickened nail plate, often with a yellow, brown, or opaque discolouration. The nail surface may appear smooth or slightly ridged, and the nail is denser and harder than normal. Unlike onychogryphosis, the nail does not typically deviate laterally or assume a ram’s horn appearance. Patients may report difficulty cutting their nails, discomfort when wearing closed footwear, and occasionally pain at the nail margins due to pressure on the surrounding soft tissue.

A thorough clinical assessment is essential before initiating treatment. The clinician should evaluate neurovascular status, particularly in patients with diabetes or peripheral arterial disease, as compromised circulation affects healing and increases infection risk. The presence of fungal infection should be considered, and nail specimens may be sent for mycological analysis where onychomycosis is suspected. Assessment of footwear is also important, as ongoing mechanical trauma will undermine any intervention.

Conservative Treatment

The primary and most commonly employed treatment for onychauxis is conservative reduction of the nail plate through mechanical debridement. This is typically performed by a podiatrist using an electric burr or nail drill, which safely reduces the thickness of the nail without trauma to the underlying nail bed. The procedure is painless when performed correctly and results in immediate patient comfort. Following reduction, the nail is filed smooth to minimise pressure and friction within footwear.

Regular professional nail care is often necessary on an ongoing basis, as onychauxis tends to recur without addressing its underlying cause. Patients with systemic conditions or poor manual dexterity — particularly the elderly — benefit from scheduled podiatric appointments every six to ten weeks for maintenance.

Emollient therapy forms an important adjunct to mechanical reduction. Regular application of urea-based creams (typically 10–40% concentration) to the nail and surrounding tissue softens the nail plate, improves pliability, and facilitates easier debridement at subsequent appointments. Urea is keratolytic and helps to gradually reduce nail thickness when used consistently. Patient education around the daily application of emollients is an important component of a conservative management programme.

Footwear advice and orthotic intervention are valuable adjuncts. Patients should be guided towards footwear with a wide, deep toe box that reduces direct pressure on the nail. In cases where structural foot deformities — such as hallux valgus or digital contractures — contribute to nail trauma, orthotic devices or toe props may offload pressure and help prevent recurrence.

Treatment of Underlying Causes

Where onychomycosis is identified as a contributing or causative factor, antifungal therapy is indicated. Topical antifungals, such as amorolfine lacquer or ciclopirox, may be effective in mild to moderate cases, though their penetration of a thickened nail plate is limited. Systemic antifungals — most commonly terbinafine — are more effective for established fungal nail infection and are typically prescribed for twelve weeks for toenail involvement. Clinicians must assess suitability based on the patient’s medical history, medications, and liver function before initiating systemic therapy.

In patients with psoriatic nail disease, treatment of the underlying psoriasis — through topical corticosteroids, intralesional injections, or systemic biologics where indicated — may improve nail appearance and reduce hypertrophy. Dermatological referral may be appropriate in complex cases.

Surgical and Chemical Avulsion

In cases where onychauxis causes significant ongoing pain, recurring infections, or where conservative measures fail to provide adequate relief, more definitive intervention may be considered. Nail avulsion — either partial or total — involves the removal of the thickened nail plate under local anaesthesia. This provides immediate relief and allows inspection of the underlying nail bed for pathology.

Chemical matrixectomy using phenol (typically an 80–88% solution) is frequently performed following avulsion to permanently ablate all or part of the nail matrix, preventing regrowth. This is particularly appropriate when the nail is severely thickened, the patient cannot tolerate recurrent debridement, or where the nail serves no functional purpose. The procedure is well-tolerated and has a high success rate, though it requires careful wound management in the postoperative period, especially in patients with vascular compromise or diabetes.

Surgical excision of the nail matrix is an alternative to chemical ablation but is less commonly performed in routine podiatric practice due to its greater invasiveness and the adequacy of phenolisation in most cases.

Onychauxis, though a benign nail condition, warrants careful assessment and appropriate management to prevent pain, infection, and functional impairment. The cornerstone of treatment remains conservative debridement by a trained podiatrist, supported by emollient therapy, footwear advice, and management of any underlying systemic or dermatological conditions. In refractory or severely symptomatic cases, chemical matrixectomy offers a definitive and effective solution. A patient-centred, holistic approach — considering the individual’s overall health status, lifestyle, and goals — is essential to achieving the best outcomes in the treatment of this common foot condition.

Onychorrhexis: Understanding Brittle, Longitudinally Ridged Nails

Nails are far more than cosmetic features. As keratinised appendages of the skin, they serve protective and sensory functions, and — perhaps most importantly from a clinical standpoint — they act as visible indicators of systemic health. Among the many nail disorders that dermatologists and clinicians encounter, onychorrhexis stands out for both its prevalence and the breadth of conditions it can signal. Characterised by longitudinal ridging and brittleness that often leads to splitting or breaking of the nail plate, onychorrhexis is a condition worth understanding in depth: its causes, its presentation, its implications, and its management.

Defining Onychorrhexis

The term “onychorrhexis” derives from the Greek words onyx (nail) and rhexis (rupture or fracture). It describes a distinctive nail abnormality in which parallel ridges run lengthwise along the nail plate, from the base toward the free edge. These ridges are frequently accompanied by increased fragility, causing the nail to split longitudinally or flake at the tip. The condition affects fingernails more commonly than toenails and can occur in both males and females, though it is somewhat more prevalent among older adults and women — two groups whose nails may be subjected to different hormonal influences and environmental stresses.

It is worth distinguishing onychorrhexis from a related but separate condition: onychoschizia, in which the nail splits horizontally into layers at the free edge. While both conditions involve nail brittleness and are sometimes grouped together under the broader category of “brittle nails,” their underlying mechanisms and typical causes can differ. Onychorrhexis involves structural disruption running the full length of the nail, suggesting a deeper disruption to nail plate formation at the matrix level.

The Structure of the Nail and How It Goes Wrong

To understand onychorrhexis, one must first appreciate normal nail architecture. The nail plate is composed of densely compacted, dead keratinised cells produced by the nail matrix — the tissue tucked beneath the proximal nail fold. These cells are arranged in horizontal layers and are bound together by intercellular lipids and structural proteins. A healthy nail plate is smooth, resilient, semi-translucent, and firmly adherent to the nail bed beneath it.

When nail matrix function is disrupted — whether by nutritional deficiency, systemic disease, physical trauma, or chemical insult — the orderly production of nail cells is disturbed. The result is a nail plate with structural weaknesses running in the direction of growth: the classic longitudinal ridges of onychorrhexis. These ridges represent lines of reduced cohesion within the nail, and the brittleness arises because the compromised intercellular bonding cannot withstand the mechanical stresses of daily life.

Causes and Risk Factors

The aetiology of onychorrhexis is multifactorial and can be broadly divided into systemic, nutritional, environmental, and local causes.

Among systemic causes, thyroid disorders — particularly hypothyroidism — are among the most frequently implicated. The thyroid hormones play an important role in regulating the growth and differentiation of epithelial cells, including those of the nail matrix. When thyroid function is impaired, nail growth slows and the structural integrity of the nail plate deteriorates. Other endocrine conditions, including hypoparathyroidism and peripheral vascular disease, can similarly compromise nail health.

Nutritional deficiencies are another significant contributor. Iron deficiency is particularly well documented; the nails depend on adequate iron-carrying haemoglobin for their oxygen supply, and when iron stores are depleted, both nail growth and quality suffer. Deficiencies in biotin (vitamin B7), zinc, protein, and essential fatty acids have also been associated with brittle, ridged nails. This connection explains why onychorrhexis is not uncommon in individuals with eating disorders, malabsorptive conditions such as coeliac disease or inflammatory bowel disease, or those following very restrictive diets.

Environmental and chemical factors account for a substantial proportion of cases, particularly among people whose hands are frequently immersed in water or exposed to harsh chemicals. Repeated wetting and drying of the nails causes the nail plate to expand and contract cyclically, weakening its structural integrity over time. Acetone-based nail polish removers, household detergents, and industrial solvents strip the nail of its natural lipid content, leaving it dry and prone to ridging and fracture. This is why onychorrhexis is so common among healthcare workers, cleaners, hairdressers, and others in occupations involving regular hand washing or chemical exposure.

Aging is itself a risk factor. As people grow older, nail growth slows and the water and lipid content of the nail plate naturally decreases, rendering it drier and more brittle. Longitudinal ridging in older adults is so common that mild onychorrhexis is often considered a normal variant of aging rather than a pathological finding.

Dermatological conditions including lichen planus, alopecia areata, and psoriasis can also produce nail changes consistent with onychorrhexis, typically through their inflammatory effects on the nail matrix. Certain medications — particularly retinoids used in the treatment of acne and psoriasis — are known to cause nail brittleness as a side effect.

Diagnosis and Clinical Evaluation

Onychorrhexis is primarily a clinical diagnosis, made on the basis of the characteristic appearance of the nails. However, because the condition can signal underlying systemic disease, a thorough evaluation is warranted when the cause is not immediately apparent. A clinician will typically take a detailed history, asking about occupation, diet, medication use, family history, and the presence of other symptoms that might point toward thyroid dysfunction, anaemia, or connective tissue disease.

Laboratory investigations may include a full blood count, thyroid function tests, serum ferritin, zinc, and albumin levels. In some cases, a biopsy of the nail matrix or nail fold may be indicated to exclude inflammatory dermatoses. Dermoscopy — the use of a handheld magnifying instrument — can assist in characterising the ridging pattern and identifying features that might suggest a specific underlying diagnosis.

Management and Treatment

Treatment of onychorrhexis is guided by its underlying cause. When a systemic condition or nutritional deficiency is identified, addressing that root cause often leads to gradual improvement in nail quality over several months — the timescale reflecting the slow growth of the nail plate (approximately three to four millimetres per month for fingernails).

For cases related to environmental exposure, protective measures are the cornerstone of management. Wearing cotton-lined gloves during wet work, reducing the frequency of nail polish remover use, and applying nail-specific moisturisers or cuticle oils can all help to restore the nail’s lipid content and reduce brittleness. Nail hardeners containing formaldehyde, paradoxically, can worsen brittleness with prolonged use and should be approached with caution.

Biotin supplementation has attracted considerable interest as a treatment for brittle nails, and several small studies have reported improvements in nail thickness and hardness. While the evidence base remains modest, biotin is generally safe and is often recommended in cases where no specific deficiency has been identified. Adequate protein and overall balanced nutrition provide the foundational building blocks for healthy nail production.

Onychorrhexis, though often dismissed as a minor cosmetic inconvenience, deserves thoughtful attention. It is a condition at the intersection of dermatology, internal medicine, and lifestyle, capable of reflecting everything from dietary gaps to thyroid disease to the cumulative toll of occupational chemical exposure. By recognising its characteristic appearance, understanding the diverse factors that contribute to it, and pursuing both systemic and topical treatments tailored to its cause, clinicians and patients alike can address not only the visible signs in the nail but the underlying conditions they represent. In this sense, the humble nail ridge carries a message well worth reading.

The Treatment of Onychophosis in the Foot

Onychophosis is a dermatological condition affecting the toenails, characterised by the hyperkeratotic accumulation of callus tissue within the nail grooves — the lateral and proximal sulci that border the nail plate. Though frequently overlooked or mistaken for other nail pathologies such as onychocryptosis (ingrown toenail) or subungual hyperkeratosis, onychophosis represents a distinct clinical entity that demands targeted management. The condition can cause significant discomfort, particularly in elderly or diabetic populations, and when left untreated, may progress to ulceration, infection, or impaired mobility. Understanding its causes, clinical presentation, and the range of available treatments is essential for effective podiatric care.

Understanding the Condition

The term onychophosis derives from the Greek words for nail (onyx) and callus (phosis), reflecting its defining feature: a localised build-up of hyperkeratotic tissue. This overgrowth occurs primarily in response to chronic mechanical pressure and friction between the nail plate and the surrounding soft tissue of the nail groove. Ill-fitting footwear is among the most common precipitating factors, as narrow toe boxes or excessive pressure from socks and hosiery concentrate force along the nail borders. Biomechanical abnormalities, including hallux valgus, hammer toe deformities, and altered gait patterns, further predispose individuals to this condition by redirecting pressure onto vulnerable nail sulci.

The great toe is most commonly affected, though any digit may develop onychophosis. Patients typically present with pain or tenderness along the nail groove, a sensation of pressure under or beside the nail, and visible thickening of the periungual skin. In severe or long-standing cases, the hyperkeratotic tissue may become macerated, fissured, or secondarily infected, introducing a risk of cellulitis or deeper soft tissue complications, particularly in those with diabetes mellitus or peripheral vascular disease.

Conservative Treatment Approaches

The cornerstone of onychophosis management is conservative, non-surgical debridement, which aims to remove the accumulated keratinous tissue and relieve pressure. This procedure is typically performed by a trained podiatrist using a scalpel, curette, or nail rasp. The practitioner carefully removes the hyperkeratotic material from within the nail sulcus without disrupting the nail matrix or surrounding healthy tissue. Regular debridement — often every six to twelve weeks depending on the rate of recurrence — is effective in managing symptoms and preventing progression for most patients.

Alongside debridement, podiatrists frequently apply emollients and keratolytic agents to soften the thickened tissue and reduce the likelihood of rapid regrowth. Preparations containing urea (typically in concentrations of 10–40%), salicylic acid, or lactic acid are commonly employed. These agents work by disrupting the protein bonds within the keratinised tissue, making it more pliable and amenable to mechanical removal. Patients are often instructed to apply these preparations at home between clinical appointments to maintain tissue suppleness and extend the interval between treatments.

Nail care and patient education are critical adjuncts to clinical treatment. Appropriate nail-cutting technique — trimming straight across rather than in a curved fashion that might encourage lateral nail spicule formation — can reduce mechanical irritation within the groove. Attention to footwear is equally important. Patients should be counselled to wear shoes with adequate toe box depth and width, ensuring that no undue pressure is applied to the nail borders during ambulation. Orthotic devices, toe props, or silicone nail sulcus protectors may be used to redistribute pressure away from the affected grooves, providing both symptomatic relief and a prophylactic benefit.

Advanced Conservative and Adjunctive Therapies

Where standard debridement and topical therapy are insufficient, several more advanced conservative interventions may be considered. Nail bracing, a technique more commonly associated with the management of involuted nails, has been applied with some success in onychophosis by reducing the transverse curvature of the nail plate and thereby alleviating pressure on the lateral sulci. Adhesive brace systems are bonded across the nail surface and gradually flatten the nail’s curvature over several weeks to months. While evidence for their use specifically in onychophosis is limited compared to ingrown nail conditions, the mechanical rationale is sound and the intervention is minimally invasive.

Padding and strapping techniques can also offer temporary but meaningful relief. Felt or foam padding placed adjacent to the nail groove deflects external pressure, while adhesive strapping of the digit can help stabilise soft tissue and reduce shear forces during weight-bearing activities. These methods are particularly valuable as interim measures while longer-term orthopaedic or footwear modifications are implemented.

Surgical and Procedural Interventions

In cases where conservative management fails to provide lasting relief, or where the structural anatomy of the toe perpetuates recurrent onychophosis, surgical options may be warranted. A partial nail avulsion — the removal of the affected lateral strip of nail — can be performed under local anaesthesia to eliminate the nail edge that contributes to sulcus pressure. This procedure is often combined with phenolisation of the nail matrix, in which phenol is applied to the avulsed nail matrix to permanently ablate that portion and prevent regrowth of the offending nail border. This combined partial nail avulsion and phenolisation approach carries a high success rate and low recurrence when performed correctly, making it a reliable option for patients who have not responded adequately to conservative care.

In patients with significant bony deformity contributing to recurrent onychophosis — such as prominent condyles of the distal phalanx or pronounced digital contractures — referral for orthopaedic or podiatric surgical assessment may be appropriate. Procedures such as digital arthroplasty or condylectomy can address the underlying structural causes, potentially offering a more definitive resolution.

Special Considerations in High-Risk Populations

Management of onychophosis in patients with diabetes mellitus, peripheral arterial disease, or immunosuppression requires particular care. In these populations, even minor trauma to the periungual tissue carries heightened risk of infection, ulceration, or impaired wound healing. Debridement should be performed with great caution, using sterile instruments and minimal tissue disruption. Phenolisation is relatively contraindicated in the presence of significant ischaemia, as wound healing may be compromised. Regular podiatric monitoring, appropriate vascular assessment, and multidisciplinary collaboration are essential components of care in these individuals.

Final Word

Onychophosis, while not life-threatening in the majority of patients, can significantly impair quality of life through chronic pain, restricted mobility, and susceptibility to secondary infection. A thorough clinical assessment, tailored to the individual’s anatomy, lifestyle, footwear habits, and comorbidities, underpins effective treatment. Conservative debridement supported by keratolytic agents, footwear modification, and patient education remains the mainstay of management. Where these measures are insufficient, surgical nail procedures or structural corrections offer durable solutions. As with many podiatric conditions, prevention — through appropriate footwear, regular professional nail care, and prompt attention to early symptoms — remains the most powerful tool available.

Overpronation in Runners: Understanding and Treating a Common Biomechanical Problem

Pronation is a natural and necessary motion of the foot. With every step, the foot rolls inward slightly upon landing, absorbing shock and distributing force across the foot and lower limb. This is a fundamental part of healthy gait mechanics. Overpronation, however, occurs when this inward rolling is excessive — the arch collapses further than it should, the ankle rolls inward past its neutral position, and the biomechanical chain running up through the knee, hip, and lower back is disrupted. For runners, who subject their bodies to thousands of repetitive foot strikes per session, overpronation can be the origin point of a range of painful and debilitating injuries. Understanding how to treat and manage this condition is essential knowledge for any serious runner, coach, or clinician working in sports medicine.

The Biomechanical Consequences of Overpronation

To appreciate why treatment matters, it helps to understand what overpronation actually does to the body. When the foot excessively rolls inward, the tibia (shinbone) internally rotates to compensate. This creates a twisting force at the knee, placing undue stress on the medial structures of the joint. Further up the chain, the hip abductors must work harder to stabilise the pelvis, often becoming fatigued and leading to altered pelvic mechanics. Common injuries associated with overpronation include plantar fasciitis, medial tibial stress syndrome (shin splints), patellofemoral pain syndrome (runner’s knee), iliotibial band syndrome, and Achilles tendinopathy. None of these conditions are trivial, and all of them have overpronation as a recognised contributing factor.

Overpronation can result from a variety of structural causes, including flat feet (pes planus), ligamentous laxity, leg length discrepancies, or simple genetic predisposition. It can also be functional — arising from weakness or tightness in specific muscles rather than bony structure — which has important implications for how it should be treated.

Assessment and Diagnosis

Before treatment can begin, the presence and degree of overpronation must be properly assessed. A visual gait analysis — watching the runner from behind as they walk or run on a treadmill — can reveal excessive inward rolling of the ankle and arch collapse. More sophisticated analysis may involve video capture and slow-motion review, or a pressure plate assessment to examine force distribution across the plantar surface of the foot. A podiatrist or sports physiotherapist will also conduct a static assessment, examining foot posture, arch height, and the degree of subtalar joint mobility. Understanding whether the overpronation is structural or functional will guide treatment decisions considerably.

Footwear: The First Line of Defence

For many runners, appropriate footwear is the most accessible and immediately effective intervention. Motion control and stability running shoes are specifically designed to address overpronation. Stability shoes feature a denser foam or medial post on the inner side of the midsole, which resists the inward rolling of the foot and encourages a more neutral gait. Motion control shoes go further, offering maximum rigidity and support for severe overpronators.

The challenge lies in matching the runner to the right shoe. A runner with mild overpronation may benefit from a stability shoe, while a more severe case may require a motion control model. Many specialist running stores offer gait analysis services to help with this decision. It is worth noting that while appropriate footwear can significantly reduce injury risk, it addresses the symptom rather than the underlying cause and should ideally be used in conjunction with other interventions.

Orthotic Insoles

Custom or semi-custom foot orthotics are another widely used and clinically supported treatment for overpronation. A custom orthotic is manufactured from a cast or 3D scan of the individual’s foot and is designed to control subtalar joint motion, support the medial arch, and redistribute ground reaction forces more evenly. Research supports their effectiveness in reducing injury rates associated with overpronation, particularly for plantar fasciitis and medial tibial stress syndrome.

Off-the-shelf orthotics offer a more affordable alternative, though they lack the precision of custom devices. For runners with mild to moderate overpronation, a quality semi-rigid over-the-counter insole with arch support may provide adequate benefit. In either case, orthotics work best as part of a broader treatment strategy rather than as a standalone solution.

Strengthening the Intrinsic and Extrinsic Foot Muscles

Perhaps the most durable and long-term solution to functional overpronation lies in targeted strengthening. The muscles responsible for controlling pronation include the tibialis posterior, the flexor hallucis longus, the flexor digitorum longus, and the intrinsic foot muscles. When these structures are weak or inhibited, the passive structures of the foot — the plantar fascia, ligaments, and joint capsules — must bear a disproportionate load, leading to pain and injury.

A physiotherapist will typically prescribe exercises such as single-leg calf raises (which strengthen the tibialis posterior in its pronation-controlling role), arch doming exercises (which activate the intrinsic foot muscles), toe spread and grip exercises, and foot inversion work with resistance bands. Hip abductor and gluteal strengthening is also essential, as weakness here places greater demand on the foot and ankle to compensate during the stance phase of running.

These exercises require patience and consistency. Functional improvements are typically measured in weeks to months rather than days, and runners must often continue with maintenance exercises indefinitely to prevent recurrence.

Flexibility and Mobility Work

Tightness in the calf complex — particularly the gastrocnemius and soleus — is strongly associated with overpronation. When dorsiflexion (the ability to bring the foot upward toward the shin) is limited, the foot compensates by collapsing the arch inward to allow forward progression of the body over the foot. Restoring adequate calf flexibility through regular stretching, foam rolling, and soft tissue therapy can meaningfully reduce overpronation and associated injury risk.

Stretching of the plantar fascia itself, the Achilles tendon, and the hip flexors also contributes to improved lower limb mechanics in the overpronating runner.

Load Management and Gradual Return to Running

Regardless of the treatment approach, load management is critical. Overpronation-related injuries often flare up when training volume or intensity is increased too quickly. Runners experiencing pain should reduce mileage, avoid speed work and hill running temporarily, and allow adequate recovery time. A physiotherapist or coach can help design a structured return-to-running programme that gradually reintroduces load as strength and mechanics improve.

Overpronation is a complex biomechanical problem with multiple contributing factors, and its treatment demands a similarly multi-faceted approach. Appropriate footwear and orthotics can offer immediate symptom relief and injury prevention, while targeted strengthening and flexibility work address the underlying dysfunction. Effective management also requires proper assessment, patience, and a willingness to modify training in the short term in service of long-term performance and health. With the right strategy, the vast majority of runners who overpronate can continue to train and compete without significant interruption.

Os Tibiale Externum: The Hidden Bone of the Foot

The human foot is a marvel of anatomical engineering, comprising 26 bones, 33 joints, and more than 100 muscles, tendons, and ligaments working in concert to support the full weight of the body. Yet, for all this complexity, the foot occasionally harbours an additional, uninvited structure: the os tibiale externum, more commonly known as the accessory navicular. Though small and often overlooked, this sesamoid-like bone carries considerable clinical significance and has fascinated anatomists, podiatrists, and orthopaedic surgeons for centuries.

What Is the Os Tibiale Externum?

The os tibiale externum is an accessory ossicle — a supernumerary bone — located on the medial (inner) side of the foot, adjacent to the navicular bone. The navicular itself sits along the inner arch of the foot, articulating with the talus proximally and the three cuneiform bones distally. The os tibiale externum develops as a secondary centre of ossification within the substance of, or immediately adjacent to, the posterior tibial tendon’s insertion site on the navicular. It is encased within this tendon or connected to the navicular by a fibrous or fibrocartilaginous bridge, a junction known as a synchondrosis.

This accessory bone is one of the most common accessory ossicles found in the human foot, with an estimated prevalence of between 4% and 21% of the general population, depending on the imaging modality and study population used. It presents bilaterally — in both feet — in approximately 50 to 90% of affected individuals, suggesting a strong genetic underpinning. It is slightly more common in females than males, and it tends to become symptomatic during adolescence when the foot is undergoing rapid growth and the demands placed on the musculoskeletal system intensify.

Classification and Anatomy

Anatomists and clinicians have long recognised that the os tibiale externum does not present in a uniform fashion. The most widely accepted classification system divides it into three distinct types.

Type I is the smallest variant, a true sesamoid bone fully embedded within the posterior tibial tendon, typically measuring 2 to 3 millimetres. It sits entirely within the tendon substance and is usually an incidental finding on imaging, rarely causing symptoms.

Type II is the most clinically relevant variant and the one most commonly associated with pain. It is a larger ossicle, typically between 8 and 12 millimetres, connected to the navicular by a synchondrosis — a fibrocartilaginous union. This junction is biomechanically vulnerable. Under repetitive loading and torsional stress, the synchondrosis can become inflamed, develop microfractures, or fail entirely, producing the clinical syndrome known as accessory navicular syndrome or os tibiale externum syndrome.

Type III, sometimes called the cornuate navicular, represents a fully fused accessory ossicle that has united with the navicular proper. This produces a characteristically enlarged, horn-shaped navicular visible on plain radiographs. Because fusion has occurred, Type III is generally asymptomatic, though the altered morphology of the navicular may influence the mechanics of the arch.

Clinical Presentation and Symptoms

The os tibiale externum is often asymptomatic throughout an individual’s lifetime, discovered only incidentally on imaging performed for an unrelated reason. However, when symptoms do arise, they typically manifest as medial midfoot pain, tenderness directly over the navicular prominence, and swelling in the region of the inner arch. The overlying skin may become irritated, particularly in individuals who wear tight or poorly fitting footwear.

Symptoms most commonly emerge during adolescence, often coinciding with periods of rapid skeletal growth, increased physical activity, or both. Flat foot deformity — pes planus — is frequently associated with symptomatic accessory navicular, as a lowered medial longitudinal arch places the posterior tibial tendon under greater mechanical strain, transmitting increased stress across the synchondrosis. Activities that involve repeated inversion and eversion of the foot, such as running, dancing, and team sports, are common triggers.

Acute exacerbation can also result from direct trauma to the medial foot. A forced eversion injury — such as a rolled ankle — may stress or rupture the synchondrosis acutely, mimicking or co-existing with a navicular fracture and presenting a diagnostic challenge in the emergency setting. High-resolution imaging, including MRI, is invaluable in these scenarios, revealing bone marrow oedema, synchondral disruption, and tendon pathology that plain radiographs cannot adequately depict.

Diagnosis

Diagnosis begins with a thorough clinical assessment. A clinician will observe the contour of the medial arch, assess for the characteristic medial navicular prominence, and identify point tenderness with direct palpation. Functional assessment includes evaluating heel-rise capacity, assessing for pes planus, and examining the integrity and strength of the posterior tibial tendon.

Plain radiographs, particularly the medial oblique view, reliably demonstrate the ossicle and allow classification by type. MRI provides superior soft tissue resolution and is the gold standard for assessing the degree of synchondral inflammation, bone marrow changes, and posterior tibial tendon integrity. Technetium bone scintigraphy has historically been used to demonstrate increased uptake at the synchondrosis, confirming active stress response, though MRI has largely supplanted it in contemporary practice.

Treatment

Management is stratified according to symptom severity. Conservative treatment is the first-line approach and succeeds in the majority of cases. Rest, activity modification, and the use of non-steroidal anti-inflammatory medications can reduce acute inflammation. Orthotics designed to support the medial arch and offload the navicular prominence are particularly effective, redistributing stress away from the synchondrosis. Immobilisation in a short-leg cast or a removable walking boot is reserved for more severe or refractory presentations, allowing the inflamed synchondrosis to settle over a period of weeks.

When conservative measures fail after three to six months, surgical intervention becomes appropriate. The Kidner procedure — excision of the accessory ossicle with advancement and reattachment of the posterior tibial tendon to the navicular — remains the most commonly performed operation. Modern variations aim to preserve tendon function and restore medial arch support. Outcomes are generally favourable, with the large majority of patients reporting significant pain relief and a return to full activity.

The os tibiale externum is a small but clinically meaningful anatomical variant that sits at the intersection of embryology, biomechanics, and musculoskeletal medicine. Its presence is common, its expression variable, and its capacity to generate significant pain in active individuals well documented. Understanding its classification, the mechanisms by which it becomes symptomatic, and the spectrum of treatment options available allows clinicians to manage affected patients effectively — restoring comfort, function, and quality of life from a bone that, by rights, was never meant to be there at all.

The Treatment of Onychomycosis in the Foot

Onychomycosis — fungal infection of the nail — is one of the most prevalent dermatological conditions encountered in podiatric practice, accounting for approximately 50% of all nail disorders. It is caused primarily by dermatophytes, most commonly Trichophyton rubrum and Trichophyton mentagrophytes, though non-dermatophyte moulds and Candida species are increasingly recognised as causative organisms, particularly in immunocompromised individuals. The condition disproportionately affects the toenails over the fingernails, and its prevalence rises markedly with age, peripheral vascular disease, diabetes mellitus, and immunosuppression. Despite being perceived by some as a cosmetic nuisance, onychomycosis carries significant clinical implications including pain, difficulty ambulating, secondary bacterial infection, and considerable psychological distress. Effective management therefore demands a thorough, evidence-based approach.

Diagnosis Before Treatment

Accurate diagnosis is the essential prerequisite to any treatment programme. Clinical presentation alone — thickened, discoloured, dystrophic nails — is insufficient to confirm onychomycosis, as similar appearances can result from psoriasis, trauma, lichen planus, and other non-fungal conditions. Mycological confirmation via nail clippings sent for microscopy and culture remains the gold standard, with a sensitivity improved further by polymerase chain reaction (PCR) testing where available. Commencing antifungal therapy without laboratory confirmation risks not only treatment failure but unnecessary systemic drug exposure and cost.

Topical Antifungal Therapy

For mild to moderate onychomycosis — particularly distal and lateral subungual onychomycosis with less than 50% nail plate involvement and no matrix involvement — topical antifungal agents represent a reasonable first-line option. Amorolfine 5% nail lacquer, applied weekly, and ciclopirox 8% nail lacquer, applied daily, are the most widely used preparations. These agents penetrate the nail plate and exert their fungicidal activity directly at the site of infection, avoiding systemic side effects.

However, topical monotherapy has significant limitations. Penetration through the nail plate is inherently difficult, and cure rates with topical agents alone are modest — typically ranging from 5–15% mycological cure at 48 weeks for amorolfine monotherapy in distal subungual onychomycosis. Newer topical agents, including efinaconazole 10% solution and tavaborole 5% solution, demonstrate superior penetration profiles and have shown improved mycological cure rates in clinical trials, reaching 53% and 31% respectively in pivotal studies. These agents represent an advance in topical therapy, particularly for patients in whom systemic treatment is contraindicated.

Topical treatment is most effective when combined with nail debridement — the mechanical reduction of nail thickness — which reduces the fungal burden and improves drug penetration. Podiatrists routinely perform debridement as an adjunct to both topical and systemic treatment.

Systemic Antifungal Therapy

For moderate to severe onychomycosis, matrix involvement, or failure of topical therapy, systemic antifungal agents are the treatment of choice and offer substantially higher cure rates. Two oral agents dominate current practice: terbinafine and the triazole antifungals, principally itraconazole.

Terbinafine, an allylamine that inhibits squalene epoxidase and thus ergosterol synthesis, is considered the gold standard for dermatophyte onychomycosis. A continuous 12-week course for toenail infection achieves mycological cure rates of approximately 70–80%, with complete cure rates (mycological plus clinical) of around 35–50%. Its fungicidal rather than fungistatic mode of action and its high nail keratin affinity contribute to its efficacy. Terbinafine is generally well tolerated, though clinicians must remain alert to rare but serious adverse effects including hepatotoxicity and severe cutaneous reactions such as Stevens-Johnson syndrome. Baseline liver function testing is recommended in those with pre-existing liver disease.

Itraconazole, a triazole that inhibits cytochrome P450-dependent lanosterol 14?-demethylase, may be administered continuously (200 mg daily for 12 weeks) or via pulse dosing (400 mg daily for one week per month, for three pulses). Pulse therapy reduces drug accumulation and cost while retaining acceptable efficacy, with mycological cure rates of approximately 54–63% for toenail infection. Itraconazole has a broader spectrum of activity than terbinafine, making it preferable for non-dermatophyte and Candida-associated infections. Its significant cytochrome P450 3A4 inhibition creates numerous drug interactions, and its negative inotropic properties necessitate caution in patients with cardiac failure.

Fluconazole, administered weekly at 150–300 mg, represents an alternative for patients intolerant of or contraindicated to first-line agents, though evidence for its use in toenail onychomycosis is less robust.

Laser and Device-Based Therapies

Over the past decade, laser therapy has attracted considerable attention as a non-pharmacological treatment option. Nd:YAG lasers operating at 1064 nm, as well as diode and fractional CO2 lasers, have been investigated. The proposed mechanism involves selective photothermal destruction of fungal organisms within the nail. While short-term mycological improvement has been reported, systematic reviews have found the evidence for laser therapy to be of generally low quality, with heterogeneous methodologies and high recurrence rates. Laser treatment is not currently recommended as a primary therapy by major dermatological or podiatric guidelines, though it may have a role as an adjunct or in patients unable to tolerate pharmacological treatment.

Photodynamic therapy (PDT), using photosensitising agents activated by visible light, has also been explored with some promise, particularly for milder cases, but similarly awaits more robust evidence before entering mainstream practice.

Surgical and Mechanical Interventions

Surgical nail avulsion — partial or complete removal of the nail plate — is occasionally employed, particularly when there is marked thickening preventing adequate drug penetration, or in the context of painful subungual hyperkeratosis. Chemical avulsion using 40% urea preparations offers a less invasive alternative, softening and dissolving the nail plate over several weeks to facilitate drug delivery and reduce fungal burden.

Permanent nail ablation via matricectomy — chemical (phenol), surgical, or laser — may be considered in refractory cases or where quality of life is severely impacted by recurrent infection, accepting the consequence of permanent nail loss.

Recurrence and Prevention

Recurrence following successful treatment is a major challenge, affecting up to 50% of patients within five years. Contributing factors include re-infection from environmental reservoirs (shoes, socks, communal areas), concurrent tinea pedis, and host susceptibility factors. Long-term management must therefore incorporate prophylactic measures: antifungal foot powders, replacement of contaminated footwear, treatment of concurrent tinea pedis, and patient education on hygiene practices in communal bathing environments. In high-risk individuals — particularly those with diabetes or peripheral vascular disease — regular podiatric monitoring and preventive nail care are essential components of ongoing management.

The treatment of onychomycosis in the foot requires a patient-centred, stepwise approach guided by accurate diagnosis, severity assessment, and individual risk factors. While topical agents suffice for mild disease, systemic antifungals — principally terbinafine — remain the cornerstone of treatment for most cases. Mechanical debridement, adjunctive topical therapy, and preventive education are integral to achieving durable cure. Emerging technologies such as novel topical agents and laser therapy broaden the therapeutic landscape, though further evidence is needed to establish their definitive role. Given its high prevalence, tendency to recur, and impact on quality of life, onychomycosis warrants the careful, sustained clinical attention that effective podiatric practice affords.

Onitsuka Tiger: The Sole of a Legacy

There is a particular kind of cool that cannot be manufactured — it must be earned. Onitsuka Tiger has earned it over seven decades, threading its way from the rubble of postwar Japan to the feet of fashion editors, film icons, and athletes alike. It is a brand that has outlasted trends, survived corporate reinvention, and emerged not merely intact but celebrated. To wear Onitsuka Tiger is to participate in a lineage — part sporting history, part cultural mythology, entirely its own thing.

Origins in the Ashes

The story begins in Kobe, Japan, in 1949. Kihachiro Onitsuka was a young entrepreneur, thirty years old and possessed of a particular conviction: that sport could rebuild a nation’s spirit. Japan had just emerged from the devastation of World War II, and Onitsuka believed that physical activity — specifically, giving young people proper footwear for it — could restore a sense of purpose and dignity to a demoralised generation. He founded Onitsuka Co., Ltd. with modest capital and an almost missionary sense of purpose.

His first product was a basketball shoe, and it was here that one of footwear’s most charming origin stories was born. Struggling to design a sole that would grip the court effectively, Onitsuka reportedly found inspiration while eating octopus — the suction cups on the tentacles suggesting a pattern that could grip almost any surface. The resulting sole became a hallmark of early Onitsuka craftsmanship: functional, ingeniously observed, and rooted in everyday Japanese life.

The Tiger Stripes

By the mid-1950s, Onitsuka had shifted focus to running shoes, and in 1953 introduced the design element that would define the brand forever: the distinctive side stripe, or “tiger stripes,” that run diagonally from the sole up the lateral side of the upper. Originally a structural feature intended to reinforce the shoe, these stripes became the brand’s visual identity. Simple, bold, and immediately recognisable, they gave Onitsuka Tiger an aesthetic language that has never needed updating — only reinterpreting.

The 1960s were a period of intense global ambition. Onitsuka’s shoes were selected for Japanese athletes competing in the 1964 Tokyo Olympics, an extraordinary moment of national pride and international exposure. The shoes performed. Athletes noticed. The brand’s reputation spread beyond Japan’s borders, reaching American and European markets at a moment when running culture was beginning its long ascent into mainstream consciousness.

The American Connection

The American chapter of Onitsuka Tiger’s story involves a young accounting student named Phil Knight, who would later co-found Nike. In 1962, Knight visited the Onitsuka factory in Kobe and negotiated the rights to distribute Tiger shoes in the United States under the name Blue Ribbon Sports. For nearly a decade, Onitsuka Tigers were the performance running shoe of choice among serious American athletes — before the relationship fractured and Knight went on to build his own empire.

This episode, dramatised in Knight’s memoir Shoe Dog and later in the television series Full Count, is a reminder of how central Onitsuka Tiger was to the birth of global sneaker culture. The brand was not peripheral to that story — it was the inciting incident. It taught an American entrepreneur what a great athletic shoe could be, and the lessons learned on those Kobe factory floors rippled outward to shape the entire industry.

Kill Bill and the Cultural Moment

No account of Onitsuka Tiger’s cultural life would be complete without Quentin Tarantino. In 2003, Kill Bill: Volume 1 placed a pair of yellow and black Onitsuka Tiger Mexico 66s on Uma Thurman’s feet as she carved her way through the Crazy 88. The shoe — sleek, retro, undeniably cool — became the film’s most imitated fashion detail almost overnight. Orders surged. A generation of cinephiles who had never heard of Onitsuka Tiger went looking for those yellow shoes.

It was a masterclass in accidental branding, or perhaps deliberate brilliance — Tarantino is, after all, a connoisseur of authentic cool. The Mexico 66, originally launched in 1966 and named for the Mexico City Olympics, is now the brand’s most iconic silhouette: low-profile, clean-lined, with just enough vintage character to feel both nostalgic and current. It has been reissued in hundreds of colourways and remains one of the most recognisable shoes in the sneaker world.

The Asics Years and Renewed Independence

In 1977, Onitsuka merged with two other companies to form Asics — a name derived from the Latin phrase Anima Sana In Corpore Sano, meaning “a healthy soul in a healthy body.” For years, the Onitsuka Tiger brand was largely dormant, subsumed into Asics’ performance athletic identity. It was relaunched as a lifestyle and fashion label in 2002, operating under the Asics umbrella but with its own distinct creative direction — retro-influenced, fashion-forward, and firmly pointed at a different consumer than the serious runner reaching for Asics Gel-Kayanos.

This distinction matters. Onitsuka Tiger occupies a unique position: it carries the credibility of genuine athletic heritage without pretending to be a performance brand. It is honest about its identity — a fashion label grounded in history — and that honesty is part of its appeal. In an era when many brands manufacture heritage they don’t actually possess, Onitsuka Tiger’s decades of real history function as a kind of luxury.

Design Philosophy and Contemporary Appeal

Today, Onitsuka Tiger’s design language balances reverence and reinvention. The core archive — Mexico 66, California 78, Serrano, Fabre — is treated with curatorial seriousness, with seasonal colourways and collaborations that refresh without undermining. Collaborations with designers including Andrea Pompilio and Walter Van Beirendonck have positioned the brand firmly within high fashion, while the mainline collection maintains accessibility.

The shoes themselves remain distinctively Japanese in their construction philosophy: meticulous, considered, and attentive to materials. There is a quietness to Onitsuka Tiger design — a preference for understatement that reads as confidence rather than timidity. Where many sneaker brands scream for attention, Onitsuka Tiger tends to murmur, and somehow people lean in to listen.

A Legacy Still Being Written

What makes Onitsuka Tiger enduring is not nostalgia alone, though nostalgia plays its part. It is the coherence of a brand that has always known what it believed in: the dignity of craft, the beauty of functional design, the idea that a shoe can carry meaning beyond its materials. Kihachiro Onitsuka wanted to rebuild a nation’s spirit through sport. He built something longer-lasting than he likely imagined — a pair of stripes that still, seventy-five years on, mean something to the people who wear them.

That is a rare kind of legacy. And it fits perfectly.

Heavy Burdens: How Obesity Affects the Feet

The human foot is an engineering marvel — a complex structure of 26 bones, 33 joints, and more than 100 muscles, tendons, and ligaments, all working in precise coordination to bear the weight of the body with every step. But that marvel has limits. When excess body weight is placed upon it year after year, the foot begins to fail in ways that are painful, progressive, and often underappreciated. Obesity — defined as a body mass index (BMI) of 30 or above — places enormous mechanical and systemic stress on the feet, contributing to a wide range of conditions that can profoundly diminish quality of life.

The Mechanical Burden

The most immediate way obesity harms the feet is through sheer mechanical load. During normal walking, each foot absorbs a force equivalent to roughly 1.25 times a person’s body weight with every step. During running or stair climbing, that force can multiply to three or four times body weight. For someone who is obese, this means the structures of the foot are subjected to vastly greater pressure than they were designed to handle, day after day, year after year.

This sustained overloading has consequences at every level. The arches of the foot — the medial longitudinal arch in particular — are placed under exceptional strain. The plantar fascia, the thick band of connective tissue that supports the arch and runs from the heel to the base of the toes, becomes chronically stretched and inflamed. The result is plantar fasciitis, one of the most common and debilitating foot conditions in the world, and one that is significantly more prevalent among people with obesity. Sufferers typically experience a stabbing pain in the heel, worst during the first steps of the morning, that can persist for months or years if left untreated.

Related to plantar fasciitis is the progressive flattening of the foot that accompanies obesity. As the arch collapses under excess weight, the foot pronates — rolling inward — changing the biomechanics of the entire lower limb. This altered gait does not stay confined to the foot. It places additional stress on the ankles, knees, hips, and lower back, creating a cascade of musculoskeletal problems that often accompany obesity-related foot dysfunction.

Joint Disease and Arthritis

Obesity is one of the strongest modifiable risk factors for osteoarthritis, and the joints of the foot are not exempt. The subtalar joint, the midfoot joints, and the metatarsophalangeal joints — particularly that of the big toe — all bear excess load in obese individuals. Over time, the cartilage that cushions these joints wears away, leading to pain, stiffness, swelling, and reduced range of motion.

Gout, a form of inflammatory arthritis caused by the accumulation of uric acid crystals in joints, is also strongly associated with obesity. The big toe joint is the classic site of a gout attack, which presents as sudden, excruciating pain, redness, and swelling so severe that even the weight of a bed sheet can be intolerable. Obesity promotes hyperuricemia — elevated uric acid in the blood — by reducing the kidneys’ ability to excrete uric acid and by increasing its production through metabolic pathways linked to excess fat tissue.

Vascular and Neuropathic Complications

Obesity is a primary driver of type 2 diabetes, and the feet are among the organs most devastated by diabetic complications. Peripheral arterial disease — the narrowing of blood vessels in the legs and feet — reduces circulation to the extremities. At the same time, peripheral neuropathy damages the nerves of the feet, causing pain, tingling, numbness, or a complete loss of sensation.

The combination of poor circulation and reduced sensation is particularly dangerous. Minor injuries — a blister, a small cut, a pressure sore — may go unnoticed and untreated because the patient cannot feel them. Without adequate blood supply to support healing and immune defence, these wounds can develop into chronic ulcers that resist treatment. In severe cases, infection spreads to underlying bone and tissue, and amputation becomes necessary. Lower limb amputations are among the most feared and devastating complications of diabetic foot disease, and obesity is a central driver of the diabetes that precedes them.

Skin and Soft Tissue Problems

The feet of people with obesity are also vulnerable to a range of skin and soft tissue problems. Increased sweating and skin-to-skin contact in skin folds can create warm, moist environments in which fungal infections — particularly tinea pedis, or athlete’s foot — thrive. These infections cause itching, scaling, and cracking of the skin, and if left untreated, can open pathways for bacterial invasion.

Calluses and corns develop in response to the abnormal pressure patterns created by excessive body weight and altered gait. While these are the body’s attempt to protect vulnerable skin, they can themselves become painful and, in diabetic patients, can progress to ulceration. Swelling of the feet and ankles — peripheral oedema — is also common in obesity, resulting from both the mechanical obstruction of lymphatic and venous return by excess tissue and from the cardiac and renal strain that frequently accompanies chronic obesity.

Psychological and Social Dimensions

The impact of obesity-related foot problems extends beyond the purely physical. Chronic foot pain limits mobility, making exercise more difficult — which in turn makes weight management harder, creating a vicious cycle that can feel impossible to escape. Reduced physical activity contributes to social isolation, depression, and a declining sense of self-efficacy. Shoe fitting becomes a practical challenge as foot shape changes, and the indignity of limited footwear options adds to the psychological burden.

For many people, foot pain is not merely an inconvenience but a barrier to participation in ordinary life: shopping, walking with family, standing at work. When the feet fail, independence erodes.

A Path Forward

Understanding the profound impact of obesity on foot health underscores the importance of early intervention and preventive care. Weight reduction — even modest losses of five to ten percent of body weight — measurably reduces the mechanical load on the feet and can significantly alleviate plantar fasciitis, joint pain, and swelling. Appropriate footwear, custom orthotics, physiotherapy, and regular podiatric care can help manage existing conditions and prevent deterioration.

Ultimately, the feet are both victims and messengers. The pain they generate is a signal that the body is under systemic strain — strain that, if addressed, can be reduced. The connection between obesity and foot health is a compelling reminder that the consequences of excess weight are not abstract or distant, but immediate, concrete, and felt with every step.

Nocturnal Leg Cramps: Understanding the Night-Time Intruder

Few experiences are as jarring as being woken from a deep sleep by a sudden, vice-like pain seizing the muscles of the leg. This is the hallmark of nocturnal leg cramps (NLCs) — involuntary, painful muscle contractions that occur at night, most commonly in the calf, though the thighs and feet are not immune. Known colloquially as “charley horses,” these episodes are far more than a minor inconvenience. For millions of people worldwide, they represent a chronic disruption to sleep, wellbeing, and quality of life. Understanding their prevalence, causes, mechanisms, and management is essential — not only for those who experience them, but for the health professionals who support them.

Prevalence and Who Is Affected

Nocturnal leg cramps are remarkably common. Research indicates that between 50 and 60 percent of adults report experiencing them at some point, with approximately 30 percent of adults experiencing them at least five times per month. They affect both sexes, though they are slightly more prevalent among women, and their frequency increases considerably with age. Children are not entirely spared — around 7 percent of children also report nocturnal cramps — but the condition is predominantly one of adulthood and older age. Concerningly, up to 20 percent of sufferers experience symptoms bothersome enough to seek medical attention, speaking to the very real impact these episodes can have on daily functioning and mental health.

What Happens During a Cramp?

A nocturnal leg cramp is an involuntary contraction of a muscle that occurs without the individual’s intention or control. The episode typically begins suddenly and without warning. The muscle — most often the gastrocnemius (the large calf muscle) or the soleus beneath it — tightens into a hard, palpable knot. The pain can be severe, lasting on average around nine minutes per episode, though in some cases it may persist longer. Even after the spasm passes, residual soreness and tenderness can linger for hours, sometimes for the remainder of the following day. When cramps recur across multiple nights, or cluster in episodes throughout a single night, the cumulative sleep disruption can contribute to secondary insomnia, daytime fatigue, anxiety about sleep, and reduced overall wellbeing.

Causes and Contributing Factors

The precise mechanism behind nocturnal leg cramps remains incompletely understood, but research points most strongly to muscle fatigue and nerve dysfunction as the primary drivers, rather than the electrolyte imbalances that are commonly assumed to be responsible. That said, the picture is rarely simple, and a range of factors — lifestyle, medical, and pharmacological — can heighten an individual’s susceptibility.

Lifestyle and postural factors play a significant role. Prolonged sitting, particularly in positions that shorten the calf muscles, reduces blood supply to the legs and increases cramping risk. Standing for long periods on hard surfaces such as concrete has a similar effect. Sleeping in the supine position with feet pointed downward (plantar flexion) shortens the calf muscles during rest, making nocturnal spasms more likely. Conversely, overexertion — too much high-intensity physical activity — can fatigue the muscles sufficiently to trigger cramping during the subsequent night’s rest.

Medical conditions associated with nocturnal leg cramps include peripheral vascular disease, lumbar spinal stenosis, liver cirrhosis, chronic kidney failure, diabetic peripheral neuropathy, hyperthyroidism, and electrolyte disturbances such as low calcium or elevated potassium. Pregnancy is also a well-recognised trigger, particularly in the later trimesters. Notably, while these associations are clinically important to identify, the evidence does not always show that treating the underlying condition reliably resolves the cramps — suggesting the relationship is complex and multifactorial.

Medications are another important contributor. Several pharmacological agents are strongly associated with nocturnal leg cramps, including intravenous iron sucrose, conjugated oestrogens, raloxifene, naproxen, teriparatide, diuretics, statins, and corticosteroids. Clinicians should review a patient’s medication history when cramps are a presenting complaint, as substituting or adjusting the implicated drug may bring meaningful relief.

Differential Diagnosis

Not all nocturnal leg pain is caused by true muscle cramps. Several conditions can mimic or be confused with Nocturnal leg cramps, and accurate diagnosis is essential. Restless legs syndrome (RLS) is perhaps the most commonly confused alternative — it involves an urge to move the legs rather than a painful contraction and is typically relieved by movement rather than muscle stretching. Peripheral arterial claudication causes leg pain on exertion and is related to ischaemia. Myositis (muscle inflammation) and peripheral neuropathy can also produce leg discomfort at night. A thorough history and physical examination are usually sufficient to differentiate these conditions; laboratory investigations and specialised testing are rarely required to confirm Nocturnal leg cramps.

Management and Treatment

Managing nocturnal leg cramps encompasses both immediate relief and longer-term prevention. When a cramp strikes, the most effective immediate intervention is to stretch the affected muscle. For a calf cramp, this involves flexing the foot upward (dorsiflexion) — standing up and pressing the heel flat to the floor, or pulling the toes upward while seated. Massaging the area and applying warmth can also help relax the muscle and alleviate pain more quickly.

For prevention, a programme of regular calf and lower limb stretching — especially before bed — has good evidence behind it. Reviewing sleeping posture to avoid sustained plantar flexion is also beneficial; some individuals find that sleeping with a pillow to prop the feet in a neutral position reduces frequency. Staying well hydrated and avoiding excessive exercise in the hours before bed may further reduce risk.

In cases where cramps are frequent and disruptive, pharmacological options have been explored. Historically, quinine was widely prescribed and found to be effective, but its use is now restricted in many countries due to serious cardiac side effects. Magnesium supplementation, vitamin B complex, gabapentin, and muscle relaxants such as carisoprodol or orphenadrine have all been trialled with varying degrees of success. No single pharmacological agent has emerged as universally preferred, and treatment should always be individualised with reference to the patient’s overall health profile and comorbidities.

The Role of the Podiatrist

Podiatrists are particularly well-positioned to assess and manage nocturnal leg cramps given their expertise in lower limb biomechanics, footwear, and neuromuscular function. Gait analysis can reveal postural contributors to muscle fatigue; orthotic intervention may reduce strain on the calf and foot musculature; and foot positioning advice can minimise cramping during sleep. Podiatrists also serve an important role in identifying when Nocturnal leg cramps may be symptomatic of vascular or neurological conditions warranting referral to other specialists.

Nocturnal leg cramps are a common, often underestimated clinical problem with real consequences for sleep, mood, and daily life. While frequently benign and idiopathic, they may in some cases reflect underlying medical conditions or medication effects that warrant investigation. A thoughtful approach — combining patient education, lifestyle modification, postural strategies, stretching, and where appropriate, pharmacological support — offers the best chance of meaningful, sustained relief. No one should simply accept that disruptive nights of pain are inevitable.

Night Splints in the Treatment of Plantar Fasciitis 

Plantar fasciitis is the most common cause of heel pain in adults, affecting an estimated one in ten people at some point during their lifetime. Characterised by degeneration and inflammation of the plantar fascia at its proximal insertion on the medial calcaneal tubercle, the condition produces a well-recognised clinical pattern: sharp, stabbing heel pain that is most intense with the first steps of the morning or after periods of prolonged rest. This "post-static dyskinesia" is the hallmark of the condition and provides the conceptual basis for one of its most widely used conservative treatments — the night splint.

Night splints have been a mainstay of plantar fasciitis management for several decades. By maintaining the foot and ankle in a position of dorsiflexion throughout sleep, they aim to counteract the pathological processes that underlie morning pain. Understanding why night splints work requires an appreciation of the biomechanical and histological mechanisms driving the condition, and their clinical application is best understood within the broader context of evidence-based conservative care.

## Pathophysiology and the Rationale for Night Splints

The plantar fascia functions as a passive tension band along the undersurface of the foot, supporting the medial longitudinal arch and facilitating efficient propulsion during gait. Repetitive mechanical loading — particularly in individuals with limited ankle dorsiflexion, excessive body weight, prolonged weight-bearing occupations, or biomechanical abnormalities such as pes planus or pes cavus — leads to cumulative microtrauma at the fascial origin. This produces a cycle of failed healing and degenerative change rather than true acute inflammation, a process more accurately termed plantar fasciopathy in contemporary literature.

During sleep, the foot naturally rests in a position of plantarflexion. In this position, the plantar fascia and the intrinsic musculature of the foot are in a shortened, relaxed state. When the individual rises and bears weight, the sudden tensile loading of these contracted structures produces the characteristic pain of the first steps. Over time, nocturnal shortening may contribute to ongoing fascial tightness and impair the tissue's capacity for repair.

The night splint directly addresses this mechanism. By holding the ankle in a neutral or mildly dorsiflexed position — typically five to fifteen degrees — throughout the sleeping hours, the device maintains a gentle, sustained stretch on both the plantar fascia and the Achilles tendon-gastrocnemius-soleus complex. This prolonged low-load stretching promotes fascial elongation, reduces morning contracture, and — according to some researchers — may facilitate the remodelling of collagen fibres within the healing tissue. The result, for many patients, is a meaningful reduction in first-step pain and an improvement in overall function.

## Types of Night Splints

Night splints are available in two principal designs: posterior splints and anterior (or dorsal) splints.

Posterior night splints are the traditional design, consisting of a rigid or semi-rigid shell that runs along the back of the lower leg and under the foot, secured with straps. They hold the ankle in dorsiflexion and are effective at maintaining the desired position throughout the night. However, their bulk and rigidity are frequently cited by patients as uncomfortable, leading to poor compliance — a critical limitation in any treatment that requires nightly use over an extended period.

Anterior or dorsal night splints address this concern by positioning the shell along the front of the lower leg and the dorsum of the foot, leaving the heel and posterior calf free. Patients generally report these to be more comfortable and less disruptive to sleep, and compliance rates tend to be higher. A third variant, the sock-style or "strassburg sock," applies a gentle dorsiflexion force through a strap connected from the toe of a compression sock to the knee. While less rigid than splinted designs, it is particularly well tolerated and has demonstrated efficacy in clinical trials.

The choice between designs should be guided by individual patient factors, including tolerance, sleep position, and the degree of ankle dorsiflexion restriction. Fitting and patient education are essential: the splint must be worn consistently — ideally every night — for a minimum of one to three months to achieve meaningful benefit.

## Clinical Evidence

The evidence supporting night splints for plantar fasciitis is generally positive, though the quality of available research is variable. Multiple randomised controlled trials and systematic reviews have demonstrated that night splints produce significant reductions in pain and improvements in function compared to baseline, and are broadly comparable to other conservative interventions such as stretching programmes, orthotics, and corticosteroid injections in terms of short-to-medium-term outcomes.

A landmark study by Batt, Tanji, and Skattum demonstrated that patients using night splints alongside a standard stretching programme achieved superior outcomes compared to stretching alone. Similarly, a well-cited trial by Powell and colleagues found that night splints were significantly more effective than anti-inflammatory medication and activity modification in reducing first-step pain at eight weeks. The Strassburg sock has been evaluated in a prospective controlled trial, with results showing resolution of symptoms in the majority of participants within a mean of approximately eight weeks.

Notably, night splints appear to be particularly effective for patients with chronic plantar fasciitis — defined as symptoms persisting for more than six months — who have failed to respond to other conservative measures. In this subgroup, the addition of a night splint to an existing treatment programme frequently produces the breakthrough improvement that other modalities alone had not achieved.

## Integration into a Treatment Plan

Night splints are rarely employed in isolation. Best practice dictates their use as part of a multimodal conservative approach that may include calf and plantar fascia stretching, load management, foot orthoses, footwear modification, and — where indicated — shockwave therapy or physiotherapy-guided exercise rehabilitation. Patient education regarding the chronic, self-limiting nature of the condition, combined with realistic expectations about the timeline for recovery, is fundamental to engagement and adherence.

Compliance remains the single greatest barrier to success with night splint therapy. Clinicians should discuss this openly with patients, acknowledge the challenges of wearing a device during sleep, and explore which design is most likely to suit the individual's lifestyle and sleeping habits.


Night splints represent a well-established, biomechanically rational, and evidence-supported intervention in the conservative management of plantar fasciitis. By maintaining a sustained dorsiflexion stretch throughout the night, they directly target the nocturnal fascial shortening that underlies the condition's most disabling symptom — first-step morning pain. When appropriately selected, correctly fitted, and used consistently as part of a comprehensive treatment programme, night splints can produce meaningful clinical improvement and accelerate recovery, particularly in patients with chronic or refractory symptoms. They remain a valuable and accessible tool in the podiatric and sports medicine clinician's armamentarium.